ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Groups Urge Congress To Enact NIH Budget Increase; Encourage Individual Letters

November 3, 1995

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982

FDA Simplifies Reporting Of Adverse Events

June 18, 1993